Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (1-10 of 333) with videos related to

Pageof 34
Sort By:
Clinical Therapeutics|June 11, 2004
Supporting the validity of outcomes researchC Daniel Mullins
Clinical Therapeutics|April 13, 2005
Patient-reported outcomes: D j Vu?C Daniel Mullins
Clinical Therapeutics|March 2, 2006
The peer-review process: gifts of timeC Daniel Mullins
Clinical Therapeutics|March 9, 2010
The need to address uncertainty and heterogeneity of treatment effect in clinical studiesC Daniel Mullins
Clinical Therapeutics|June 6, 2006
Double counting and the reporting of cost per event avoidedC Daniel Mullins
The American Journal of Managed Care|April 10, 2009
New perspectives on overactive bladder and its treatment. IntroductionC Daniel Mullins
Clinical Therapeutics|April 7, 2005
Sound public health policy: Focusing on saving the most lives possibleC Daniel Mullins
Clinical Therapeutics|June 28, 2005
Physician prescribing and the hippocratic oathC Daniel Mullins
Clinical Therapeutics|March 24, 2009
Pharmaceutical use and outcomes in childrenC Daniel Mullins
Clinical Therapeutics|March 18, 2008
An invitation to the health policy debatesC Daniel Mullins
Pageof 34

Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
Clinical Therapeutics|June 11, 2004
Supporting the validity of outcomes researchC Daniel Mullins
Clinical Therapeutics|April 13, 2005
Patient-reported outcomes: D j Vu?C Daniel Mullins
Clinical Therapeutics|March 2, 2006
The peer-review process: gifts of timeC Daniel Mullins
Clinical Therapeutics|March 9, 2010
The need to address uncertainty and heterogeneity of treatment effect in clinical studiesC Daniel Mullins
Clinical Therapeutics|June 6, 2006
Double counting and the reporting of cost per event avoidedC Daniel Mullins
The American Journal of Managed Care|April 10, 2009
New perspectives on overactive bladder and its treatment. IntroductionC Daniel Mullins
Clinical Therapeutics|April 7, 2005
Sound public health policy: Focusing on saving the most lives possibleC Daniel Mullins
Clinical Therapeutics|June 28, 2005
Physician prescribing and the hippocratic oathC Daniel Mullins
Clinical Therapeutics|March 24, 2009
Pharmaceutical use and outcomes in childrenC Daniel Mullins
Clinical Therapeutics|March 18, 2008
An invitation to the health policy debatesC Daniel Mullins
Pageof 34